Ulcerative colitis: open trials in Greece

18 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Evangelismos General Hospital of Athens, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital of Heraklion, Heraklion · Ippokrateio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-11-04
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Evangelismos General Hospital of Athens, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital of Heraklion, Heraklion · Ippokrateio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-11-04
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Evangelismos S A, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · General Hospital Of Athens Korgialenio Benakio H R C, Athens · University General Hospital of Heraklion, Heraklion · University General Hospital of Ioannina, Ioannina · Geniko Nosokomeio Peiraia Tzaneio, Piraeus
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
General Hospital of Athens "G. Gennimatas", Athens · Evangelismos S A, Athens · Hippokration Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Heraklion, Heraklion · General University Hospital Of Patras, Patras
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Athens · Heraklion · Thessaloniki
Registry updated 2026-10-30
2024-511458-32-00
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · Hippokration Hospital, Thessaloniki
Registry updated 2026-10-26
2025-524404-29-00
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Trial Treatment · Phase 2 · Eli Lilly & Co.
Thoracic General Hospital of Athens "I Sotiria", Athens · Evangelismos S A, Athens · University General Hospital of Heraklion, Heraklion · Ippokratio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-10-21
NCT05003947
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis
Trial Treatment · Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine
Prodromos Stem Cell Institute, Athens
Registry updated 2026-10-20
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn’s Disease (CD)
Trial Treatment · Phase 2 · Takeda Development Center Americas Inc.
Thoracic General Hospital of Athens "I Sotiria", Athens · Evaggelismos Hospital, Athens · General Hospital of Athens "G. Gennimatas", Athens · Alexandra Hospital, Athens · University General Hospital of Heraklion, Heraklion · General University Hospital Of Patras, Patras
Registry updated 2026-10-20
NCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
University General Hospital Attikon, Athens · Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · Hippokration Hospital, Thessaloniki
Registry updated 2026-10-20
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Athens
Registry updated 2026-10-16
NCT07071519
A Study to Assess the Adverse Events, Effectiveness, and How the Drug Moves through the Body of Intravenous and Subcutaneous Injections of Risankizumab in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · AbbVie Deutschland GmbH & Co. KG
University General Hospital Attikon, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Hippokration Hospital, Thessaloniki
Registry updated 2026-09-25
NCT05442567
A Long-term Study in Children and Teenagers with Ulcerative Colitis or Crohn’s Disease treated with Vedolizumab IV
Trial Treatment · Phase 3 · Takeda Development Center Americas Inc.
University General Hospital Attikon, Athens · Nosokomeio Paidon I Agia Sofia, Athens · Ippokratio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-09-03
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics Inc.
General Hospital of Athens "G. Gennimatas", Athens · Evangelismos S A, Athens · Hippokration Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Heraklion, Heraklion · General University Hospital Of Patras, Patras
Registry updated 2026-08-24
NCT07463183
A clinical trial of MK-8690 in people with ulcerative colitis (MK-8690-002)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Thoracic General Hospital of Athens "I Sotiria", Athens · Evangelismos S A, Athens
Registry updated 2026-08-23
NCT05782907
Ulcerative Colitis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Abbvie Deutschland GmbH & Co. KG
Nosokomeio Paidon I Agia Sofia, Athens · University General Hospital of Heraklion, Heraklion
Registry updated 2026-08-05
NCT06257875
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
Trial Treatment · Phase 2 · AbbVie Deutschland GmbH & Co. KG
Evaggelismos Hospital, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital of Heraklion, Heraklion · Ippokratio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-06-09
2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
Hippokration Hospital, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Evangelismos S A, Athens · Alexandra Hospital, Athens · University General Hospital of Heraklion, Heraklion · University General Hospital of Ioannina, Ioannina · General Oncological Hospital Of Kifissia Agioi Anargyroi, Kifissia
Registry updated 2026-04-01

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error